Gefitinib Terminated Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00082667Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast
NCT00206492Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients
NCT00206414Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer